mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |